Q2 FY2026 EarningsQ2 FY2026 results missed consensus on the top and bottom lines: revenue of $0.29M missed the $0.33M estimate, and the net loss of $6.07M was wider than the $5.14M expected. Despite the miss, GAAP EPS of -$0.19 was in-line with expectations due to a significant increase in the weighted average share count (+109% YoY). The company confirmed that top-line data for the Phase 2b ELPIS II trial in HLHS remains on track for September 2026.
Overview: Longeveron(LGVN) the Revenue is 287 K (-9.18%), Miss estimate;the EBIT is -6.171 M (-14.34%), Miss estimate;the EPS is -1.9 (+42.42%), Meet estimate.